High materiality8/10
H.C. Wainwright Reiterates Buy Rating on Dyne Therapeutics (DYN)
Why it may matterVerify against the original reporting
Bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
H.C. Wainwright reiterates Buy rating on DYN; target $50; current price $25.70; positive price movement (+1.75) since signal.
- Wainwright reiterates Buy on DYN.
- Target $50; price now $25.70; +1.75 since signal.
Key facts
- 01
Target: $50
- 02
Posted price: $25.7
- 03
Analyst firm: H.C. Wainwright
- 04
Analyst: Andrew Fein
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.